December 19, 2017 / 12:09 PM / a year ago

BRIEF-Asterias Biotherapeutics Completes Enrollment Of Entire SCiStar Study​

Dec 19 (Reuters) - Asterias Biotherapeutics Inc:

* ASTERIAS BIOTHERAPEUTICS INC - ‍COMPLETES ENROLLMENT OF ENTIRE SCISTAR STUDY​

* ASTERIAS BIOTHERAPEUTICS - ‍SIX- AND TWELVE-MONTH READOUTS FROM THIRD, FOURTH AND FIFTH COHORTS OF TRIAL ALL PROJECTED TO OCCUR IN 2018 FOR AST-OPC1​

* ASTERIAS BIOTHERAPEUTICS INC - ‍ANTICIPATE EXPANDING EFFICACY DATASET FOR AST-OPC1 FROM 6 SUBJECTS IN COHORT 2 TO A TOTAL OF 22 SUBJECTS BY END OF 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below